Suppr超能文献

第二剂水痘疫苗作为暴露后预防的有效性:一项前瞻性队列研究。

Effectiveness of second-dose varicella vaccination as post-exposure prophylaxis: a prospective cohort study.

机构信息

Xuhui District Centre for Disease Control and Prevention, Shanghai, China.

School of Public Health, University of South China, Hunan Province, China.

出版信息

Clin Microbiol Infect. 2019 Jul;25(7):872-877. doi: 10.1016/j.cmi.2018.11.013. Epub 2018 Nov 23.

Abstract

OBJECTIVES

Although administration of a second dose of varicella vaccine (2-dose VarV) to individuals who have previously received one-dose VarV has been recommended as a post-exposure prophylaxis (PEP) strategy for outbreak control, the effectiveness of this strategy remains unclear. We evaluated the vaccine effectiveness (VE) of 2-dose VarV as PEP among students involved in 129 varicella outbreaks in Shanghai, China from 2013 to 2016.

METHODS

Students who had received one-dose VarV more than 5 years prior to varicella exposure were eligible to receive 2-dose VarV as PEP. We evaluated the VE using the following formula: VE = (1 - hazard ratio (HR)) × 100%.

RESULTS

A total of 6762 students were eligible for 2-dose VarV, of whom 58.6% accepted PEP after varicella exposure. The adjusted VE of 2-dose VarV as PEP was 77% (95% confidence interval 64-85%). In addition, the adjusted VE of 2-dose VarV as PEP in affected classrooms with high vaccine uptake was higher than that in classrooms with lower vaccine uptake (87% vs. 69%). The adjusted VE was also higher in students who received 2-dose VarV within 3 days of exposure than those who received it more than 3 days post exposure (77% vs. 64%).

CONCLUSIONS

These Results suggest that administration of 2-dose VarV as PEP is an appropriate intervention for outbreak control in countries where two-dose VarV has not been adopted.

摘要

目的

尽管向曾接种过一剂水痘疫苗(2 剂 VarV)的个体接种第 2 剂 VarV 已被推荐作为暴发控制的暴露后预防(PEP)策略,但该策略的有效性仍不清楚。我们评估了 2 剂 VarV 作为 PEP 在上海的 129 起水痘暴发中对学生的疫苗效力(VE),这些暴发发生于 2013 年至 2016 年。

方法

曾在水痘暴露前 5 年以上接种过一剂 VarV 的学生有资格接种 2 剂 VarV 作为 PEP。我们使用以下公式评估 VE:VE =(1 - 风险比(HR))×100%。

结果

共有 6762 名学生有资格接种 2 剂 VarV,其中 58.6%在水痘暴露后接受了 PEP。2 剂 VarV 作为 PEP 的调整 VE 为 77%(95%置信区间 64-85%)。此外,在疫苗接种率较高的受影响教室中,2 剂 VarV 作为 PEP 的调整 VE 高于疫苗接种率较低的教室(87%比 69%)。在暴露后 3 天内接种 2 剂 VarV 的学生中,调整后的 VE 也高于暴露后超过 3 天接种 2 剂 VarV 的学生(77%比 64%)。

结论

这些结果表明,在尚未采用 2 剂 VarV 的国家,接种 2 剂 VarV 作为 PEP 是控制暴发的一种适当干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验